enVVeno Medical financials at a glance

+ Portfolio

The revenue of enVVeno Medical is reported as 0 billion Dollars in the fiscal year 2023. The earnings were -1.91 Dollars per share in 2023, which was 13.4 lower than 2021. And about -0.01904 billion Dollars are reported as free cash flow in the financials of enVVeno Medical 2023. No dividends were paid to the shareholders of the enVVeno Medical stock NasdaqCM:NVNO in the financial year 2023.

$0.00M

Revenue

$-2.20

Earnings Per Share

0.00%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

0.00

Earnings Per Share

-2.20

Gross Margin %

0.00

Free Cash Flow

0.00

Financials

Year	Year	TTM	2022	2021	2020	2019
Rev.	Revenue	N/A	$0.00M	$0.00M	$0.00M	$0.03M
GM %	Gross Margin %	0.00%	0.00%	0.00%	0.00%	100.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-2.54	$-2.20	$-1.94	$-7.54	$-12.00
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0
Sha.	Shares	N/AM	9.47M	9.47M	8.5M	0.77M
OCF	Operating Cash Flow	N/A	$-15.62M	$0.00M	$-7.68M	$0.00M
FCF	Free Cash Flow	N/A	$-15.74M	$0.00M	$-7.86M	$0.00M
FCFS	Free Cash Flow Per Share	$-1.88	$-1.66	$-1.41	$-6.08	$-9.93

enVVeno Medical financials at a glance

Financials

Discover